These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
380 related items for PubMed ID: 17428248
21. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y. Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114 [Abstract] [Full Text] [Related]
22. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Dhar NB, Jones JS, Reuther AM, Dreicer R, Campbell SC, Sanii K, Klein EA. BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201 [Abstract] [Full Text] [Related]
23. Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma. Dragicevic D, Djokic M, Pekmezovic T, Vuksanovic A, Micic S, Hadzi-Djokic J, Tulic C, Milenkovic D, Pljesa-Ercegovac M, Simic T. Urol Int; 2009 Apr; 82(3):335-40. PubMed ID: 19440024 [Abstract] [Full Text] [Related]
24. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S. BJU Int; 2007 Jul; 100(1):33-6. PubMed ID: 17552951 [Abstract] [Full Text] [Related]
25. Contemporary management of the urethra in patients after radical cystectomy for bladder cancer. Clark PE, Hall MC. Urol Clin North Am; 2005 May; 32(2):199-206. PubMed ID: 15862617 [Abstract] [Full Text] [Related]
26. [Primary upper urinary tract tumors and subsequent location in the bladder]. Azémar MD, Audouin M, Revaux A, Misraï V, Comperat E, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O, Rouprêt M. Prog Urol; 2009 Oct; 19(9):583-8. PubMed ID: 19800544 [Abstract] [Full Text] [Related]
27. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: oncological outcomes at 7 years. Berger A, Haber GP, Kamoi K, Aron M, Desai MM, Kaouk JH, Gill IS. J Urol; 2008 Sep; 180(3):849-54; discussion 854. PubMed ID: 18635229 [Abstract] [Full Text] [Related]
28. The oncological results of laparoscopic nephroureterectomy for upper urinary tract transitional cell cancer are equal to those of open nephroureterectomy. Waldert M, Remzi M, Klingler HC, Mueller L, Marberger M. BJU Int; 2009 Jan; 103(1):66-70. PubMed ID: 18710438 [Abstract] [Full Text] [Related]
29. Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy. Wang P, Luo JD, Wu WF, Wang S, Cai SL, Shen BH, Shi SF, Wei KX, Zhang ZG, Chen ZD. Braz J Med Biol Res; 2007 Jul; 40(7):979-84. PubMed ID: 17653452 [Abstract] [Full Text] [Related]
30. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma. Walton TJ, Sherwood BT, Parkinson RJ, Obakponovwe O, Thomas SA, Taylor MC, England RC, Lemberger RJ. J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866 [Abstract] [Full Text] [Related]
31. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG. J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213 [Abstract] [Full Text] [Related]
32. [An analysis of upper urinary tract recurrence following radical cystectomy for bladder cancer]. Sugi M, Fukui K, Yoshida K, Inui H, Kawakita S, Murota T, Kinoshita H, Matsuda T. Hinyokika Kiyo; 2010 Feb; 56(2):87-90. PubMed ID: 20185992 [Abstract] [Full Text] [Related]
33. Survival analysis in patients with upper urinary tract transitional cell carcinoma: a comparison between open and hand-assisted laparoscopic nephroureterectomy. Hsueh TY, Huang YH, Chiu AW, Huan SK, Lee YH. BJU Int; 2007 Mar; 99(3):632-6. PubMed ID: 17166239 [Abstract] [Full Text] [Related]
35. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M. Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379 [Abstract] [Full Text] [Related]
36. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary? Wo JY, Shipley WU, Dahl DM, Coen JJ, Heney NM, Kaufman DS, Zietman AL. BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448 [Abstract] [Full Text] [Related]
37. [Transitional carcinomas of the urinary tract: synchronous and metachronous lesions]. Arrizabalaga M, Navarro J, Mora M, Castro M, Extramiana J, Mañas A, Diez J, Paniagua P. Actas Urol Esp; 1994 Sep; 18(8):782-96. PubMed ID: 7998507 [Abstract] [Full Text] [Related]